We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 44

Senator Schumer Introduces Legislation to Decriminalize Marijuana at the Federal Level
  • Kelley Drye & Warren LLP
  • USA
  • June 29 2018

Making good on this April 20th announcement, Senator Chuck Schumer (D-NY) introduced legislation that would upend current federal regulation of


FDA Commissioner Continues To Roll Out Digital Health Initiatives
  • Kelley Drye & Warren LLP
  • USA
  • May 7 2018

FDA Commissioner Scott Gottlieb trumpeted the agency’s “modern and flexible” approach to digital health regulation when speaking at Health Datapalooza


Unanimous Recommendation for Cannabis-Based Epilepsy Drug; Trump Administration Lifts Threat of Cannabis Enforcement in States With Legalization; Schumer To Introduce Bill Decriminalizing Marijuana
  • Kelley Drye & Warren LLP
  • USA
  • April 20 2018

On this auspicious April 20th, three developments in the world of cannabis regulation caught our attention. The first is the unanimous recommendation


FDA Clears mHealth App That Uses AI to Signal Signs of Stok
  • Kelley Drye & Warren LLP
  • USA
  • February 28 2018

FDA announced last week that it has cleared for marketing an mHealth app that uses artificial intelligence (AI) to analyze CT images for signs of


Think Your Prescription Drug Advertising is Beyond NAD’s Purview? NAD Disagrees.
  • Kelley Drye & Warren LLP
  • USA
  • February 6 2018

Those of us who spend our days at the intersection of law and advertising of health products generally accept that the prescription drug world is a


FDA Releases 2018 Roadmap: Focus On Digital Health Continues
  • Kelley Drye & Warren LLP
  • USA
  • January 16 2018

Last week, FDA released a document outlining its policy priorities for the coming year. “Healthy Innovation, Safer Families: FDA’s 2018 Strategic


H.R. 3985 Calls For Public-Private Working Group to Study Medical Device Security
  • Kelley Drye & Warren LLP
  • USA
  • October 18 2017

The “Internet of Medical Things Resiliency Partnership Act of 2017” was introduced in the House of Representative earlier this month. Co-sponsored by


FDA and EPA Issue Joint Guidance On Jurisdiction Over Mosquito-Related Products
  • Kelley Drye & Warren LLP
  • USA
  • October 12 2017

Last week, FDA and the EPA issued guidance for industry regarding each agency’s respective jurisdiction over mosquito-related products. With the


Digital Health Update: Tech and Health Care Giants Selected for FDA’s Pre-Cert Program
  • Kelley Drye & Warren LLP
  • USA
  • October 11 2017

In his keynote address at the AdvaMed annual conference in late September, FDA Commissioner Scott Gottlieb returned to the themes of promoting


Senate Expected to Vote on Gottlieb Nomination Next Week
  • Kelley Drye & Warren LLP
  • USA
  • May 4 2017

Today, Senate Majority Leader Mitch McConnell (R-KY) filed cloture on the nomination of Dr. Scott Gottlieb to be the next FDA Commissioner. A cloture